The New Standard of Care: Leveraging the Benefits of SGLT2 Inhibitors Across the Heart Failure Spectrum

The New Standard of Care: Leveraging the Benefits of SGLT2 Inhibitors Across the Heart Failure Spectrum

October 08, 2023 07:00am
October 08, 2023 08:15am

Join us at HFSA 2023 for a live satellite symposium where Javed Butler, MD, and Lee Goldberg, MD, will discuss the importance of integrating SGLT2 inhibitors across the spectrum of heart failure.

Faculty:

Javed Butler, MD 
Lee Goldberg, MD

Provided by Clinical Care Options, LLC in collaboration with Heart Failure Society of America.
This activity is supported by independent educational grants from Boehringer Ingelheim Pharmaceuticals, Inc. and Eli Lilly and Company.